Lord, Abbett & Co
NVO

Lord, Abbett & Co’s Novo Nordisk NVO Stock Holding History

Lord, Abbett & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-766,402
Closed -$51.9M – 618
2022
Q4 		$51.9M Buy
766,402
+122,894
+19% +$7.21M 0.19% 157
2022
Q3 		$32.1M Sell
643,508
-1,201,964
-65% -$64.4M 0.12% 235
2022
Q2 		$103M Buy
1,845,472
+752,356
+69% +$41.7M 0.36% 69
2022
Q1 		$60.7M Buy
+1,093,116
New +$56.1M 0.16% 188

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Lord, Abbett & Co's NVO Position: Q1 2023 in Review

Lord, Abbett & Co sold out of Novo Nordisk (NVO) in Q1 2023, closing a stake of 766,402 shares — an estimated $51.9M sold.

Lord, Abbett & Co first reported a position in NVO in Q1 2022 and held it in 4 quarters. The position peaked at $103M in Q2 2022. 1,146 funds tracked by Wall St. Rank hold NVO as of Q1 2023.

  • Lord, Abbett & Co reported no remaining Novo Nordisk position as of Q1 2023 after selling out during the quarter.
  • Lord, Abbett & Co sold 766,402 Novo Nordisk shares in Q1 2023, an estimated $51.9M.
  • Lord, Abbett & Co first reported a position in Novo Nordisk in Q1 2022 and held it in 4 quarters.
  • Lord, Abbett & Co's Novo Nordisk position peaked at $103M in Q2 2022.
  • 1,146 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2023.

Based on Lord, Abbett & Co's 13F filing for Q1 2023, filed 12 May 2023.